← Back
$MLTX All transactions

MoonLake Immunotherapeutics

▼ SELL 10b5-1 Plan

$ Value

$47K

Shares

2,426

Price

$20

Filed

Apr 16

Insider

Name

Bodenstedt Matthias

Title

Chief Financial Officer

CIK

0001920545

Roles

Officer

Transaction Details

Transaction Date

2026-04-14

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,186,084

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025. | The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $19.500 to $19.625. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

Filing Info

Accession No.

0001213900-26-044642

Form Type

4

Issuer CIK

0001821586

Bodenstedt Matthias's History

Date Ticker Type Value
2026-04-14 MLTX $47K
2026-04-10 MLTX $38K
2026-04-09 MLTX $1.6M
2025-10-08 MLTX $99K

Other Insiders at MLTX (90d)

Insider Bought Sold Last
BVF PARTNERS L P/IL $63.0M 2026-03-31
Santos da Silva Jorge
Chief Executive Officer
$2.8M 2026-04-13
Bodenstedt Matthias
Chief Financial Officer
$1.7M 2026-04-10